InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Equillium, Inc.

EQ Clue Score53
United States Fiscal year ends December CIK 0001746466 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Stephen Connelly
5 Jun 2026
President and CSO
Sell
30,975
$2.94
$91.07K
Christine Zedelmayer
5 Jun 2026
Sr. Vice President and COO
Sold after exercise
14,584
$2.93
$42.74K
Stephen Connelly
4 Jun 2026
President and CSO
Sell
200,000
$3.16
$632.76K
Christine Zedelmayer
28 May 2026
Sr. Vice President and COO
Sold after exercise
30,208
$2.98
$90.02K
Christine Zedelmayer
28 May 2026
Sr. Vice President and COO
Sold after exercise
200
$2.71
$542.00
Christine Zedelmayer
28 May 2026
Sr. Vice President and COO
Sold after exercise
55,604
$2.70
$150.13K
Penny Tom
28 May 2026
Principal Accounting Officer
Sold after exercise
65,000
$2.95
$191.75K
Christine Zedelmayer
27 May 2026
Sr. Vice President and COO
Sold after exercise
9,821
$2.70
$26.52K
Christine Zedelmayer
13 Mar 2026
Sr. Vice President and COO
Sold after exercise
120,312
$2.50
$300.82K
Christine Zedelmayer
9 Mar 2026
Sr. Vice President and COO
Sold after exercise
181,219
$2.00
$362.44K
Christine Zedelmayer
19 Feb 2026
Sr. Vice President and COO
Sold after exercise
76,562
$1.74
$133.26K
Christine Zedelmayer
19 Feb 2026
Sr. Vice President and COO
Sold after exercise
109,375
$1.78
$194.84K
Penny Tom
8 Jan 2026
Principal Accounting Officer
Sold on a plan
6,533
$1.29
$8.43K
Christine Zedelmayer
23 Dec 2025
Sr. Vice President and COO
Sold after exercise
100,000
$1.50
$150.00K
Christine Zedelmayer
15 Dec 2025
Sr. Vice President and COO
Sold on a plan
11,900
$1.31
$15.59K
Christine Zedelmayer
12 Dec 2025
Sr. Vice President and COO
Sold on a plan
23,804
$1.34
$31.90K
Christine Zedelmayer
25 Nov 2025
Sr. Vice President and COO
Sold on a plan
7,998
$0.95
$7.60K
Christine Zedelmayer
25 Nov 2025
Sr. Vice President and COO
Sold on a plan
100
$0.98
$98.00
Jason A Keyes
23 Jan 2025
Chief Financial Officer
Sold on a plan indirect
10,000
$0.65
$6.50K
Jason A Keyes
14 Nov 2024
Chief Financial Officer
Sold on a plan indirect
10,000
$0.70
$7.00K
Penny Tom
28 Oct 2024
Principal Accounting Officer
Sold on a plan
2,835
$1.25
$3.54K
Christine Zedelmayer
28 Oct 2024
Sr. Vice President and COO
Sold on a plan
15,000
$1.25
$18.75K
Penny Tom
25 Oct 2024
Principal Accounting Officer
Sold on a plan
683
$1.25
$853.75
Jason A Keyes
26 Sep 2024
Chief Financial Officer
Sold on a plan indirect
10,000
$0.81
$8.10K
Penny Tom
16 Sep 2024
Principal Accounting Officer
Sold on a plan
38,806
$0.85
$32.99K
Jason A Keyes
16 Jul 2024
Chief Financial Officer
Sold on a plan indirect
10,000
$0.87
$8.70K
Jason A Keyes
29 Aug 2022
Chief Financial Officer
Sell indirect
7,000
$2.83
$19.81K
Jason A Keyes
6 Jun 2022
Chief Financial Officer
Sell indirect
5,000
$2.52
$12.60K
Jason A Keyes
4 Apr 2022
Chief Financial Officer
Sell indirect
8,000
$3.18
$25.44K
Jason A Keyes
1 Dec 2021
Chief Financial Officer
Sell indirect
5,000
$5.08
$25.40K
Christine Zedelmayer
16 Nov 2021
Sr. Vice President and COO
Sold after exercise
7,350
$5.49
$40.31K
Christine Zedelmayer
16 Nov 2021
Sr. Vice President and COO
Sold after exercise
4,084
$5.49
$22.40K
Stephen Connelly
6 Oct 2021
Chief Scientific Officer
Sold after exercise
2,467
$7.01
$17.29K
Stephen Connelly
6 Oct 2021
Chief Scientific Officer
Sold after exercise
5,625
$7.01
$39.42K
Jason A Keyes
27 Sep 2021
Chief Financial Officer
Sell indirect
8,000
$6.74
$53.92K
Jason A Keyes
27 Jul 2021
Chief Financial Officer
Sell indirect
5,000
$5.72
$28.59K
Stephen Connelly
8 Jun 2021
Chief Scientific Officer
Sold after exercise
10,495
$7.18
$75.32K
Stephen Connelly
7 Jun 2021
Chief Scientific Officer
Sold after exercise
13,900
$7.14
$99.26K
Stephen Connelly
7 Jun 2021
Chief Scientific Officer
Sold after exercise
8,490
$7.08
$60.14K
Stephen Connelly
4 Jun 2021
Chief Scientific Officer
Sold after exercise
7,030
$7.01
$49.25K
Stephen Connelly
4 Jun 2021
Chief Scientific Officer
Sold after exercise
6,509
$7.01
$45.60K
Jason A Keyes
26 May 2021
Chief Financial Officer
Sell indirect
5,000
$6.50
$32.48K
Stephen Connelly
28 Dec 2020
Chief Scientific Officer
Sell
25,000
$4.52
$113.05K
Jason A Keyes
23 Dec 2020
Chief Financial Officer
Sell indirect
8,000
$4.74
$37.91K
Stephen Connelly
28 Sep 2020
Chief Scientific Officer
Sell
25,000
$5.62
$140.40K
Stephen Connelly
13 Jul 2020
Chief Scientific Officer
Sell
250,000
$8.13
left out
Jason A Keyes
18 Feb 2020
Chief Financial Officer
Sell indirect
5,000
$5.03
$25.14K
Jason A Keyes
21 Jan 2020
Chief Financial Officer
Sell indirect
5,000
$4.41
$22.04K
Jason A Keyes
3 Sep 2019
Chief Financial Officer
Sell indirect
5,000
$3.60
$17.98K
Jason A Keyes
1 Aug 2019
Chief Financial Officer
Sell indirect
5,000
$3.99
$19.94K

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 20
Sales at will 17
Transactions with no price 1
Shares from compensation/vesting 1,297,109
Sales filed before the plan box existed 15
History held since 16 Oct 2018